ArriVent BioPharma, Inc. (AVBP) shares outstanding
ArriVent BioPharma, Inc. (AVBP) had 38.46M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 22.2% higher than the 31.47M of fiscal 2024. Figures as of 18 Nov 2026, 11:57 UTC, from Yahoo Finance.
Key facts
- Shares outstanding, fiscal 2025
- 38.46M
- Change on fiscal 2024
- +22.2%
- Highest on record
- 38.46Mfiscal 2025
- Lowest on record
- 31.47Mfiscal 2024
- Fiscal years on record
- 42022–2025
Figures as of . Statements from Yahoo Finance. Figures, not advice.
ArriVent BioPharma, Inc. shares outstanding, in more detail
The market data feed counts 51.72M shares outstanding today.
Across the 4 fiscal years on record (2022–2025), the highest was 38.46M in fiscal 2025 and the lowest 31.47M in fiscal 2024.
Shares outstanding by fiscal year
ArriVent BioPharma, Inc. shares outstanding, year by year
| Fiscal year | Shares outstanding | Change | Year ended |
|---|---|---|---|
| 2025 | 38.46M | 22.2% up | |
| 2024 | 31.47M | 1.5% down | |
| 2023 | 31.96M | 0.0% | |
| 2022 | 31.96M | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.
How to read it
A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.
ArriVent BioPharma, Inc., figure by figure
- ArriVent BioPharma, Inc. market cap
- ArriVent BioPharma, Inc. revenue
- ArriVent BioPharma, Inc. earnings
- ArriVent BioPharma, Inc. earnings per share (EPS)
- ArriVent BioPharma, Inc. P/E ratio
- ArriVent BioPharma, Inc. P/S ratio
- ArriVent BioPharma, Inc. P/B ratio
- ArriVent BioPharma, Inc. free cash flow
- ArriVent BioPharma, Inc. operating margin
- ArriVent BioPharma, Inc. dividend
- ArriVent BioPharma, Inc. total debt
- ArriVent BioPharma, Inc. cash on hand
- ArriVent BioPharma, Inc. total assets
- ArriVent BioPharma, Inc. return on equity (ROE)
- ArriVent BioPharma, Inc. return on invested capital (ROIC)
ArriVent BioPharma, Inc. (AVBP) overview: price, valuation and scorecard
ArriVent BioPharma, Inc. shares outstanding: questions and answers
How many shares does ArriVent BioPharma, Inc. have?
ArriVent BioPharma, Inc. (AVBP) had 38.46M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 22.2% higher than the 31.47M of fiscal 2024. The market data feed counts 51.72M shares outstanding today.
What are the highest and lowest diluted share count figures on record for ArriVent BioPharma, Inc.?
Across the 4 fiscal years on record (2022–2025), the highest was 38.46M in fiscal 2025 and the lowest 31.47M in fiscal 2024.
How is ArriVent BioPharma, Inc.'s diluted share count calculated?
The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For ArriVent BioPharma, Inc. it is on record here for 4 fiscal years, 2022 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: shares outstanding
All stocks guides →- What market capitalization is, and what it is not
Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “ArriVent BioPharma, Inc. (AVBP) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/AVBP/shares-outstanding
Underlying data: Yahoo Finance.